TORONTO, ON — May 23, 2002 —
A new device that combines blood glucose monitoring and insulin delivery designed to help people better manage their diabetes is now available in Canada.
Novo Nordisk Canada Inc. and LifeScan Canada Ltd. have partnered to develop the new InDuo System. This new compact and discreet device combines two of the daily activities that are essential for many people with diabetes — blood glucose monitoring and insulin delivery.
This first-of-its-kind system is designed to offer assistance with achieving good blood glucose control, a vital component in managing diabetes. For many people with this disease, regular blood glucose monitoring and injecting the appropriate amount of insulin at the right time can be difficult. Also, for those newly diagnosed with diabetes, learning about and following through with both blood glucose monitoring and insulin injection can be a daunting process.
The InDuo System was designed to help solve those problems. As a combined insulin doser and blood glucose monitor, the InDuo System offers insulin users the opportunity to make more informed dosing decisions with the benefit of blood glucose test results. The system is also conveniently small and discreet, making it easy to use anywhere, anytime.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!